[The significance of the inhibition of increased sympathetic activity in renal diseases].
Katedra i Klinika Nefrologi AM w Poznaniu.
Stanisław
S
Czekalski
Krzysztof
K
Pawlaczyk
D018663:Adrenergic Agents / Q000627:therapeutic use; D018674:Adrenergic Antagonists / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D051437:Renal Insufficiency / Q000188:drug therapy / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*
D018663:Adrenergic Agents; D018674:Adrenergic Antagonists